Last week, the U.S. Drug Enforcement Administration (DEA) released its long-awaited proposed rule on Suspicious Orders Monitoring System (SOMS) obligations under the federal Controlled Substances Act. ...more
In the prepublication version of today’s Federal Register, the U.S. Drug Enforcement Agency (DEA) issued an interim final rule (IFR) implementing conforming changes to DEA’s regulations as a result of the Agricultural...more
8/21/2020
/ Agribusiness ,
Cannabidiol (CBD) oil ,
Cannabis Products ,
Comment Period ,
DEA ,
Decriminalization of Marijuana ,
Farm Bill ,
Interim Final Rules (IFR) ,
Marijuana ,
Marijuana Cultivation ,
Marijuana Related Businesses ,
Regulatory Oversight ,
Regulatory Requirements
Agency seeks input on “comparative advantage” requirement for new opioids -
Yesterday, as part of its ongoing efforts to combat the current opioid crisis, FDA published a draft guidance, “Opioid Analgesic Drugs:...more
6/21/2019
/ Applications ,
Comment Period ,
FDA Approval ,
Food and Drug Administration (FDA) ,
Opioid ,
Pharmaceutical Industry ,
Prescription Drugs ,
Public Meetings ,
Regulatory Standards ,
Risk Assessment ,
Rulemaking Process